Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
europe
3
×
atlantic food labs
berlin
biotech
boehringer ingelheim
cbt
clinical trials
diabetes
eli lilly
empagliflozin
europe blog main
europe top stories
fda
fundings & exits
health
healthcare
huel
indiana blog main
indiana top stories
life sciences
livongo
london
mysugr
national blog main
national health service
new york blog main
new york top stories
obesity
prediabetes
recent funding
seedcamp
slgt2 inhibitor
soylent
startups
tc
telemedicine
type 1 diabetes
type 2 diabetes
united kingdom
united states
What
diabetes
3
×
digital
type
acquired
acquisition
ago
aimed
approval
austria
based
bid
boehringer
care’s
centered
combines
companies
condition
drug
eli
emerged
evidence
exits
expand
fallen
fda
food
free
giant
habitual
health
healthtech
heart
help
independent
ingelheim
insurance
lilly
london
loss
maintain
Language
unset
Current search:
diabetes
×
europe
×
@techcrunch.com
2 years ago
Habitual is using digital support plus food replacement to help reverse type 2 diabetes
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@techcrunch.com
6 years ago
Diabetes platform mySugr exits to Roche for as much as $100M
